Nutrisystem (NTRI) Tops Q2 EPS by 18c; Raises Outlook

Nutrisystem (NASDAQ: NTRI) reported Q2 EPS of $0.80, $0.18 better than the analyst estimate of $0.62. Revenue for the quarter came in at $194.9 million versus the consensus estimate of $180.76 million.

GUIDANCE:

Nutrisystem sees FY2017 EPS of $1.84-$1.95, versus the consensus of $1.69. Nutrisystem sees FY2017 revenue of $684-694 million, versus the consensus of $660.5 million.

The Company’s third quarter and updated full year 2017 guidance are outlined below. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.

• Third quarter revenue is expected to be in the range of $153 to $158 million, net income between $13.0 and $14.3 million, diluted income per common share between $0.42 and $0.47, and adjusted EBITDA between $25.6 and $27.6 million.
• Full year 2017 revenue is now expected to be in the range of $684 to $694 million compared to the previous range of $650 to $665 million, net income between $56.1 and $59.0 million compared to the previous range of $49.9 to $52.9 million, diluted income per common share between $1.84 and $1.94 compared to the previous range of $1.65 to $1.75, and adjusted EBITDA between $107.1 and $111.3 million compared to the previous range of $100.0 to $104.5 million.

For earnings history and earnings-related data on Nutrisystem (NTRI) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c